Error: Could not add to watchlist. X

Spectral Medical Inc

+ Watchlist
SDI:CN
Ticker Change
SDI:CN has changed to a new ticker symbol
CAD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (CAD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Medical Equipment & Devices
Sub-Industry
Life Science Equipment

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Spectral Medical Inc is inPhase III, seeking FDA approval for its theranostics product for the treatment of severe sepsis and septic shock. Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. Directed by the Company's Endotoxin Activity Assay, Spectral's EUPHRATES trial is a theranostics trial in the area of sepsis.
ADDRESS
135 2 The West Mall
Toronto, ON M9C 1C2
Canada
PHONE
1-416-626-3233
  • Paul M Walker
    President/CEO
  • Anthony Businskas
    Exec VP/CFO/Secy
  • Gualtiero Guadagni
    VP:Sales & Marketing
  • Debra Foster
    VP:Clinical Development
  • Ali Mahdavi
    Investor Relations
Show More